Initial architecture of the REACTION platform and its components
Posted by on 30. March 2011 00:00

To evaluate the first year of the REACTION project and plan for the next 6 months, project partners met for the third REACTION Project Board Meeting on 21-23 March 2011, organised by partner IMM on their premises in Mainz. Partners presented and discussed the technical and scientific progress made which has resulted in the definition of an initial architecture for the REACTION platform.


Extended News

Initial prototypes and demonstrators were presented, including a concept demonstrator for the primary care scenario, showing how devices monitor different parameters, e.g. weight or blood pressure, and immediately transmit the results to a server and, if necessary, on to a health professional.

For the in-hospital scenario, a demo tablet was shown with functions for blood glucose management, including clinical decision support and with connection to the existing hospital system.


To ensure that the further development of the platform and prototypes fits clinical practice, clinical partners went through the necessary requirements for diabetes management in primary care and in-hospital care.

In primary care, the focus is on preventing or delaying the typical progression of the disease and the co-morbidities as a starting point for managing the disease, supporting the patient and thus preventing further complications. This calls for functions such as patient education, feedback to patients and support, dietary advice and connectivity to the Electronic Patient Record.

For diabetes care in the hospital, it is a matter of keeping blood glucose levels within a certain range to prevent hyperglycaemia and hypoglycaemia. To accomplish this, it is essential that the staff is trained in the fundamentals of glucose control. The current functions of the in-hospital prototype include patient information, insulin dose, blood glucose profile, administered insulin and therapy measures but will also have to accommodate workflow management.


The activities for the next months will deal with further developments of the prototypes based on updated user requirements which emerge from clinical workshops and experience.


A great deal of work has been done since the partners last met, some of which is described in the deliverables created and submitted during the last six months. These cover disease management strategies and risk assessment tools, safety issues in REACTION applications, health care economics and reimbursements, validation framework and many more. The list can be viewed on the project website and the public deliverables downloaded when they have been reviewed and approved by the EC.